>
Organization
Incyte Corp.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Incyte Corp.

... for the treatment of systemic lupus erythematosus (SLE) in partnership with Incyte Corporation (NASDAQ:INCY). Systemic lupus erythematosus (SLE) is a chronic, multi-organ autoimmune disease that ...
... PR Newswire Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced today that the U.S. Food and Drug Administration (FDA) ...
... Incyte Corporation (Nasdaq:INCY) announced today that it will present at the following investor conferences ...
... candidate DPX-Survivac, low dose cyclophosphamide, and 100 mg or 300 mg of Incyte's IDO1 enzyme inhibitor epacadostat in patients with advanced recurrent ovarian cancer. In ...
... She has also received consulting fees and research funding from Bayer; Genentech; Incyte; LAM Therapeutics; MEI; Merck; Millennium; and Roche; and reports a financial interest ...
... Incyte Corporation (Nasdaq:INCY) announces updated results from its pivotal Phase 2 REACH1 study evaluating ...
... MPN Heroes® Recognition Program is made possible by the generous support of Incyte Corporation, a global biopharmaceutical company that discovers and develops novel medicines to ...
... partner at Third Rock Ventures.The change follows some ups and downs for Incyte's portfolio over the past year, which saw the axe fall on its ...
... Incyte named Dashyant Dhanak, Ph.D. as Executive Vice President and Chief Scientific Officer, ...
Subscribe now for full coverage on Incyte Corp.
Start My Free Trial